Mrw. Langenfeld et al., IS ENDOGENOUS ERYTHROPOIETIN A PATHOGENETIC FACTOR IN THE DEVELOPMENTOF ESSENTIAL-HYPERTENSION, Nephrology, dialysis, transplantation, 12(6), 1997, pp. 1155-1160
Background. Recent experimental studies have found that erythropoietin
elicits vasoconstriction and proliferation of endothelial cells. We c
onducted the following study to assess the possible interactions betwe
en endogenous erythropoietin, systemic and renal haemodynamics at diff
erent stages of essential hypertension. Methods. We examined 47 patien
ts with borderline essential hypertension (age 26+/-3 years) and 49 pa
tients with established essential hypertension WHO stage I-II (age 52/-10 years), and compared them to 42 normotensive individuals (age 26/-3 years). The concentration of erythropoietin (radioimmunoassay), 24
-h ambulatory blood pressure (Spacelab 90207), systemic haemodynamics
(Doppler sonography) and renal haemodynamics (para-aminohippuric acid
and inulin clearance) were determined. Results. Erythropoietin was wit
hin normal range and similar among the three groups. In patients with
established essential hypertension, a close correlation was found betw
een erythropoietin and systolic (r=0.45, P<0.002) and diastolic (r=0.5
1, P<0.001) ambulatory blood pressure. In contrast, ambulatory blood p
ressure was not correlated with erythropoietin in subjects with border
line hypertension. Total peripheral resistance (r=0.41, P<0.02) was li
nked to erythropoietin in established but not in borderline hypertensi
on. However, erythropoietin was inversely correlated with renal plasma
flow in both established and borderline hypertension (r=-0.33, P<0.05
, and r=-0.34, P<0.05 respectively). In normotensive subjects, in cont
rast, erythropoietin was not correlated with any of the determined var
iables. In neither group erythropoietin was linked to the haematocrit
or hemoglobin concentration. Conclusion. The correlation between eryth
ropoietin and renal vascular changes which is already present in borde
rline hypertension and is confirmed in established hypertension indica
tes an involvement of erythropoietin in the development of essential h
ypertension. The presence of normal concentrations of endogenous eryth
ropoietin in all groups suggests a dysregulation of erythropoietin in
patients with essential hypertension as the pathophysiological link be
tween erythropoietin and vascular changes.